PER 0.00% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-28

  1. 420 Posts.
    lightbulb Created with Sketch. 471
    Akki, not sure toxicity is non clinical. I'm more concerned about lack of capital being the non clinical worry. With no partners as yet, and the potential to go alone, I expect a raising soon (hopefully after other indications). We can then put that behind us and move up nicely.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 7.9¢ $33.53K 416.4K

Buyers (Bids)

No. Vol. Price($)
2 92000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 65186 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.